Published in Br J Pharmacol on December 03, 2007
Neuron-glia crosstalk gets serious: role in pain hypersensitivity. Curr Opin Anaesthesiol (2008) 1.99
Targeting astrocyte signaling for chronic pain. Neurotherapeutics (2010) 1.88
A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain (2008) 1.64
A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1. Immunity (2009) 1.14
Emerging role of astroglia in pain hypersensitivity. Jpn Dent Sci Rev (2010) 0.91
Interleukin (IL)-1 and IL-6 regulation of neural progenitor cell proliferation with hippocampal injury: differential regulatory pathways in the subgranular zone (SGZ) of the adolescent and mature mouse brain. Brain Behav Immun (2010) 0.90
Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety. Drug Des Devel Ther (2014) 0.89
Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes. Adv Biol Regul (2014) 0.85
A biological perspective of CSF lipids as surrogate markers for cognitive status in HIV. J Neuroimmune Pharmacol (2013) 0.82
Heroin-induced conditioned immunomodulation requires expression of IL-1β in the dorsal hippocampus. Brain Behav Immun (2013) 0.78
Diabetes impairs an interleukin-1β-dependent pathway that enhances neurite outgrowth through JAK/STAT3 modulation of mitochondrial bioenergetics in adult sensory neurons. Mol Brain (2013) 0.77
Salvianolic Acid B Ameliorates Cerebral Ischemia/Reperfusion Injury Through Inhibiting TLR4/MyD88 Signaling Pathway. Inflammation (2016) 0.76
Fatigue in rheumatic diseases. Eur J Rheumatol (2015) 0.75
Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2. Oncotarget (2016) 0.75
Glial activation: a driving force for pathological pain. Trends Neurosci (2001) 3.98
Cytokines and acute neurodegeneration. Nat Rev Neurosci (2001) 3.70
Src kinases: a hub for NMDA receptor regulation. Nat Rev Neurosci (2004) 3.65
Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci (2003) 3.38
Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke (1995) 2.81
Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat Med (2001) 2.16
Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci U S A (2000) 2.08
Interleukin-1beta promotes repair of the CNS. J Neurosci (2001) 1.92
The immune system and memory consolidation: a role for the cytokine IL-1beta. Neurosci Biobehav Rev (2001) 1.74
Interleukin-1: a master regulator of neuroinflammation. J Neurosci Res (2004) 1.69
Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential. Brain Behav Immun (2003) 1.64
Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J Neuroimmunol (1989) 1.59
Inflammation in central nervous system injury. Philos Trans R Soc Lond B Biol Sci (2003) 1.56
IL-1-regulated responses in astrocytes: relevance to injury and recovery. Glia (2005) 1.56
A neuromodulatory role of interleukin-1beta in the hippocampus. Proc Natl Acad Sci U S A (1998) 1.47
Neonatal infection-induced memory impairment after lipopolysaccharide in adulthood is prevented via caspase-1 inhibition. J Neurosci (2005) 1.41
Interleukin-1beta induces a reactive astroglial phenotype via deactivation of the Rho GTPase-Rock axis. J Neurosci (2004) 1.40
Induction of interleukin-6 in axotomized sensory neurons. J Neurosci (1995) 1.39
Molecular basis of sickness behavior. Ann N Y Acad Sci (1998) 1.39
Interleukin-1 is an astroglial growth factor in the developing brain. J Neurosci (1988) 1.25
The type 1 interleukin-1 receptor is essential for the efficient activation of microglia and the induction of multiple proinflammatory mediators in response to brain injury. J Neurosci (2002) 1.24
A dual role for interleukin-1 in LTP in mouse hippocampal slices. J Neuroimmunol (2003) 1.17
Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur J Pharmacol (1990) 1.17
Neuronal, astroglial and microglial cytokine expression after an excitotoxic lesion in the immature rat brain. Eur J Neurosci (2000) 1.16
Interleukin-1 beta released by gp120 drives neural death through tyrosine phosphorylation and trafficking of NMDA receptors. J Biol Chem (2006) 1.16
Ceramide mediates the rapid phase of febrile response to IL-1beta. Proc Natl Acad Sci U S A (2006) 1.16
(Peri)vascular production and action of pro-inflammatory cytokines in brain pathology. Clin Sci (Lond) (2007) 1.14
Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Mol Cell Neurosci (2002) 1.12
Induction of interleukin-6 by depolarization of neurons. J Neurosci (2000) 1.10
Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain. J Cereb Blood Flow Metab (2000) 1.10
SRC kinase inhibition improves acute outcomes after experimental intracerebral hemorrhage. Stroke (2007) 1.08
IL-1beta induces a MyD88-dependent and ceramide-mediated activation of Src in anterior hypothalamic neurons. J Neurochem (2006) 1.06
Interleukin-6 mRNA expression by cortical neurons in culture: evidence for neuronal sources of interleukin-6 production in the brain. J Neuroimmunol (1995) 1.00
The anti-inflammatory cytokine, interleukin (IL)-10, blocks the inhibitory effect of IL-1 beta on long term potentiation. A role for JNK. J Biol Chem (2001) 0.96
Interleukin 1beta modulates rat subfornical organ neurons as a result of activation of a non-selective cationic conductance. J Physiol (2003) 0.94
Involvement of caspases and calpains in cerebrocortical neuronal cell death is stimulus-dependent. Br J Pharmacol (2002) 0.92
Interleukin-1 beta increases synaptic inhibition in rat hippocampal pyramidal neurons in vitro. Regul Pept (1992) 0.91
IL-1 beta signalling in glial cells in wildtype and IL-1RI deficient mice. Br J Pharmacol (2002) 0.89
Interleukin-1 beta inhibits glutamate release in hippocampus of young, but not aged, rats. Neurobiol Aging (1997) 0.88
Involvement of interleukin-1beta in the mechanism of human immunodeficiency virus type 1 (HIV-1) recombinant protein gp120-induced apoptosis in the neocortex of rat. Neuroscience (1999) 0.87
Mechanisms of interleukin-6 synthesis and release induced by interleukin-1 and cell depolarisation in neurones. Mol Cell Neurosci (2007) 0.87
Mechanisms of regulation of tyrosine phosphorylation of NMDA receptor subunit 2B after cerebral ischemia/reperfusion. Acta Pharmacol Sin (2000) 0.83
An interleukin-1 receptor fragment inhibits spontaneous sleep and muramyl dipeptide-induced sleep in rabbits. Am J Physiol (1996) 0.82
PC12 cells express IL-1 receptor type I and response to IL-1beta stimulation. Respir Physiol Neurobiol (2007) 0.79
Expression of interleukin-6 is suppressed by inhibition of voltage-sensitive Na+/Ca2+ channels after cerebral ischemia. Neuroreport (2000) 0.78
A role for brown adipose tissue in diet-induced thermogenesis. Nature (1979) 6.20
Cytokines and acute neurodegeneration. Nat Rev Neurosci (2001) 3.70
Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration. Immunology (1992) 3.09
Lipocortin-1: cellular mechanisms and clinical relevance. Trends Pharmacol Sci (1994) 2.71
A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatry (2005) 2.41
Cytokines and the nervous system. I: Expression and recognition. Trends Neurosci (1995) 2.28
Role of IL-1alpha and IL-1beta in ischemic brain damage. J Neurosci (2001) 2.20
Inflammation and brain injury: acute cerebral ischaemia, peripheral and central inflammation. Brain Behav Immun (2009) 2.13
Systemic infection, inflammation and acute ischemic stroke. Neuroscience (2008) 2.03
Luxuskonsumption, diet-induced thermogenesis and brown fat: the case in favour. Clin Sci (Lond) (1983) 1.93
Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology (1995) 1.86
Muscling in on salbutamol. Lancet (1992) 1.80
Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull (1992) 1.80
Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration. Immunology (1997) 1.76
Circulating interleukin-6 mediates the febrile response to localised inflammation in rats. J Physiol (2000) 1.75
Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab (1996) 1.72
Interleukin-1 and inflammatory neurodegeneration. Biochem Soc Trans (2007) 1.67
Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab (1998) 1.63
Tumour necrosis factor-alpha-induced migration of human Langerhans cells: the influence of ageing. Br J Dermatol (2002) 1.59
Altered protein tyrosine phosphorylation in asthmatic bronchial epithelium. Eur Respir J (2005) 1.56
Leptin actions on food intake and body temperature are mediated by IL-1. Proc Natl Acad Sci U S A (1999) 1.56
Effect of diet and cold exposure on norepinephrine turnover in brown adipose tissue of the rat. J Clin Invest (1982) 1.56
Dendritic cell accumulation in draining lymph nodes during the induction phase of contact allergy in mice. Int Arch Allergy Appl Immunol (1989) 1.55
Divergent immune responses to respiratory and contact chemical allergens: antibody elicited by phthalic anhydride and oxazolone. Clin Exp Allergy (1992) 1.54
Activation of brown adipose tissue thermogenesis by the ventromedial hypothalamus. Nature (1981) 1.50
Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proc Natl Acad Sci U S A (1992) 1.49
Tumor necrosis factor alpha is a critical component of interleukin 13-mediated protective T helper cell type 2 responses during helminth infection. J Exp Med (1999) 1.47
Phenotypic characteristics of antigen-bearing cells in the draining lymph nodes of contact sensitized mice. Immunology (1990) 1.46
T helper cell 2 immune skewing in pregnancy/early life: chemical exposure and the development of atopic disease and allergy. Br J Dermatol (2015) 1.43
MHC class II expression by Langerhans' cells and lymph node dendritic cells: possible evidence for maturation of Langerhans' cells following contact sensitization. Immunology (1991) 1.42
Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4. J Immunol (1993) 1.38
Modulation of epidermal Langerhans' cell frequency by tumour necrosis factor-alpha. Immunology (1994) 1.33
Alpha 6 integrins are required for Langerhans cell migration from the epidermis. J Exp Med (1997) 1.32
Antigen-bearing dendritic cells in the draining lymph nodes of contact sensitized mice: cluster formation with lymphocytes. Immunology (1991) 1.31
Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes. J Mol Endocrinol (2005) 1.29
Chronic effects of beta 2-adrenergic agonists on body composition and protein synthesis in the rat. Biosci Rep (1984) 1.26
Salbutamol, a beta 2-adrenoceptor agonist, increases skeletal muscle strength in young men. Clin Sci (Lond) (1992) 1.26
The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma. Clin Exp Allergy (2003) 1.25
The local lymph node assay: a viable alternative to currently accepted skin sensitization tests. Food Chem Toxicol (1996) 1.25
Endogenous interleukin-1 receptor antagonist is neuroprotective. Biochem Biophys Res Commun (1997) 1.25
Lipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain. J Exp Med (1991) 1.24
Systemic migration of dendritic cells during contact sensitization. Immunology (1990) 1.24
Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Res (1995) 1.23
Cytokines and Langerhans cell mobilisation in mouse and man. Cytokine (2005) 1.22
Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy. Allergy (2011) 1.20
The progression and topographic distribution of interleukin-1beta expression after permanent middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab (1999) 1.20
Lipocortin 1 fragment modifies pyrogenic actions of cytokines in rats. Am J Physiol (1990) 1.19
Interleukin-1beta and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. Eur J Neurosci (1998) 1.17
Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization. Clin Exp Allergy (2005) 1.17
Influence of noradrenaline on blood flow to brown adipose tissue in rats exhibiting diet-induced thermogenesis. Pflugers Arch (1981) 1.17
Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1beta in the rat. J Cereb Blood Flow Metab (1998) 1.16
Further evaluation of the local lymph node assay in the final phase of an international collaborative trial. Toxicology (1996) 1.15
An ICE inhibitor, z-VAD-DCB attenuates ischaemic brain damage in the rat. Neuroreport (1996) 1.15
Regulation of energy balance. Annu Rev Nutr (1981) 1.14
Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats. Am J Physiol (1999) 1.14
A role for insulin in the diet-induced thermogenesis of cafeteria-fed rats. Metabolism (1981) 1.12
Transport of interleukin-1 across cerebromicrovascular endothelial cells. Br J Pharmacol (2009) 1.12
Assessment of the safety of foods derived from genetically modified (GM) crops. Food Chem Toxicol (2004) 1.11
Thermogenic effects of the antiglucocorticoid RU-486 in the rat: involvement of corticotropin-releasing factor and sympathetic activation of brown adipose tissue. Endocrinology (1989) 1.11
Identification of dendritic cells as a major source of interleukin-6 in draining lymph nodes following skin sensitization of mice. Immunology (1995) 1.11
Excitotoxic brain damage in the rat induces interleukin-1beta protein in microglia and astrocytes: correlation with the progression of cell death. Glia (1999) 1.11
Increased proton conductance pathway in brown adipose tissue mitochondria of rats exhibiting diet-induced thermogenesis. Nature (1980) 1.11
Brain sites of action of endogenous interleukin-1 in the febrile response to localized inflammation in the rat. J Physiol (1999) 1.09
Induction of respiratory hypersensitivity to diphenylmethane-4,4'-diisocyanate (MDI) in guinea pigs. Influence of route of exposure. Toxicology (1994) 1.09
Langerhans cell migration. Clin Exp Dermatol (2000) 1.09
The effect of ultraviolet B irradiation and urocanic acid isomers on dendritic cell migration. Immunology (1992) 1.09
Role of tumour necrosis factor-alpha in ultraviolet B light-induced dendritic cell migration and suppression of contact hypersensitivity. Immunology (1994) 1.09
Interleukin-1 receptor antagonist inhibits endotoxin fever and systemic interleukin-6 induction in the rat. Am J Physiol (1996) 1.09
Why are some proteins allergens? Toxicol Sci (2000) 1.08
Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy. Br J Pharmacol (2009) 1.08
Anabolic effects of clenbuterol on skeletal muscle are mediated by beta 2-adrenoceptor activation. Am J Physiol (1992) 1.06
Assessment of the functional activity of antigen-bearing dendritic cells isolated from the lymph nodes of contact-sensitized mice. Int Arch Allergy Appl Immunol (1989) 1.05
Interleukin 1 beta and the stimulation of Langerhans cell migration: comparisons with tumour necrosis factor alpha. Arch Dermatol Res (1997) 1.04
The effects of ultraviolet radiation on the human immune system. Br J Dermatol (1999) 1.04
Immunotoxicology: suppressive and stimulatory effects of drugs and environmental chemicals on the immune system. A discussion. Arch Toxicol (1989) 1.04
Intercellular adhesion molecule-1 (ICAM-1) expression by lymph node dendritic cells: comparison with epidermal Langerhans cells. Immunol Lett (1992) 1.04
IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: regulation by lactoferrin. Clin Exp Immunol (2003) 1.03
Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-alpha- and IL-1beta-dependent mechanism. Immunology (2001) 1.03
A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses. J Appl Toxicol (1999) 1.03
The rapid rejection of allogeneic lymphocytes by a non-adaptive, cell-mediated mechanism (NK activity). Immunology (1985) 1.02
Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany. Cell Mol Life Sci (2011) 1.02
Tumour necrosis factor-alpha induces Langerhans cell migration in humans. Br J Dermatol (1999) 1.02
Biological activity and brain actions of recombinant rat interleukin-1alpha and interleukin-1beta. Eur Cytokine Netw (1998) 1.01
Sympathetic activation of brown-adipose-tissue thermogenesis in cachexia. Biosci Rep (1981) 1.01
Differential stimulation of immune function by respiratory and contact chemical allergens. Immunology (1991) 1.01
The bronchial epithelium in asthma--much more than a passive barrier. Monaldi Arch Chest Dis (2001) 1.00
Effect of chronic food restriction on energy balance, thermogenic capacity, and brown-adipose-tissue activity in the rat. Biosci Rep (1982) 1.00
Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J Neurosci (1995) 0.99
Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J Immunol (2001) 0.99
Beta-adrenoreceptors in rat brown adipose tissue: proportions of beta 1- and beta 2-subtypes. Am J Physiol (1985) 0.98
Diet-induced thermogenesis. Pharmacol Ther (1982) 0.98
Effects of manipulating dietary protein and energy intake on energy balance and thermogenesis in the pig. J Nutr (1980) 0.98
Interactions of IFN-gamma with IL-3 and IL-4 in the regulation of serotonin and arachidonate release from mouse peritoneal mast cells. Immunology (1994) 0.98
The Hapten-Atopy hypothesis II: the 'cutaneous hapten paradox'. Clin Exp Allergy (2011) 0.98
Intracellular phosphotyrosine induction by major histocompatibility complex class II requires co-aggregation with membrane rafts. J Biol Chem (1999) 0.97
Leptin affects food intake via CRF-receptor-mediated pathways. Nat Neurosci (1998) 0.96
Effects of diet and acute noradrenaline treatment on brown adipose tissue development and mitochondrial purine-nucleotide binding. Q J Exp Physiol (1982) 0.96
Regional blood flow and skeletal muscle energy status in endotoxemic rats. Am J Physiol (1987) 0.96
Local cytokine induction by LPS in the rat air pouch and its relationship to the febrile response. Am J Physiol (1997) 0.96